During the past decade, Northeast Cardiology Associates conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northeast Cardiology Associates" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Biotronik, Inc." with 3 trials sponsored, "NewAmsterdam Pharma" with 2 trials sponsored, "Arginox Pharmaceuticals" with 1 trials sponsored and "Baim Institute for Clinical Research" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northeast Cardiology Associates" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Daiichi Sankyo, Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Baim Institute for Clinical Research" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Northeast Cardiology Associates" are "Coronary Artery Disease" (6 trials), "Angina Pectoris" (2 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials) and "Myocardial Ischemia" (2 trials). Many other conditions were trialed in "Northeast Cardiology Associates" in a lesser frequency.

Most popular intervention types in "Northeast Cardiology Associates" are "Drug" (10 trials), "Device" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Obicetrapib" (2 trials), "Anti-arrhythmic drugs" (1 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northeast Cardiology Associates" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Northeast Cardiology Associates". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Northeast Cardiology Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Northeast Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".